Sun Pharma Advanced Research Company Ltd is engaged in the business of research and development (R&D) of pharmaceutical products.
Financial Results:
Sun Pharma Advanced Research Company Ltd reported Revenues for Q4FY24 of ₹17.00 Crores down from ₹48.00 Crore year on year, a fall of 64.58%.
Total Expenses for Q4FY24 of ₹128.00 Crores down from ₹140.00 Crores year on year, a fall of 8.57%.
Consolidated Net Profit of -₹107.00 Crores from -₹82.00 Crores in the same quarter of the previous year.
The Earnings per Share is -₹3.29, from -₹2.53 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.